Bull case
BF-B would need investors to value it at roughly 24x earnings — about 8x more generous than today's 16x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where BF-B stock could go
BF-B would need investors to value it at roughly 24x earnings — about 8x more generous than today's 16x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 18x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 4x multiple contraction could push BF-B down roughly 27% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Brown-Forman is a premium spirits company that produces and markets iconic alcoholic beverage brands like Jack Daniel's whiskey. It generates revenue primarily through the sale of its spirits portfolio—with Jack Daniel's representing over half of sales—and also earns income from barrel sales and contract bottling services. The company's moat lies in its century-old brand equity, particularly the globally recognized Jack Daniel's trademark, which commands pricing power and consumer loyalty.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $0.36/$0.47 | -24.3% | $924M/$1.0B | -9.2% |
| Q4 2025 | $0.47/$0.47 | +1.5% | $1.0B/$1.0B | +3.0% |
| Q1 2026 | $0.58/$0.47 | +24.5% | $1.1B/$1.0B | +5.3% |
| Q2 2026 | $0.12/$0.31 | -61.2% | $912M/$885M | +3.1% |
BF-B beat EPS estimates in 2 of 4 tracked quarters. Mixed delivery makes the upcoming report a key data point for re-rating.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $28 — implies +4.8% from today's price.
| Metric | BF-B | S&P 500 | Consumer Defensive | 5Y Avg BF-B |
|---|---|---|---|---|
| Forward PE | 15.7x | 18.8x-17% | 14.2x+10% | — |
| Trailing PE | 17.4x | 24.4x-29% | 18.9x | 27.3x-36% |
| PEG Ratio | — | 1.66x | 1.92x | — |
| EV/EBITDA | 12.9x | 15.2x-15% | 11.1x+16% | 20.5x-37% |
| Price/FCF | 13.9x | 20.7x-33% | 15.3x | 43.1x-68% |
| Price/Sales | 3.2x | 3.1x | 0.9x+259% | 5.7x-44% |
| Dividend Yield | 3.43% | 1.91% | 3.06% | 2.33% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolBF-B generates $893M in free cash flow at a 22.7% margin — 13.7% ROIC signals a durable competitive advantage · returns 6.7% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~2.1 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 18, 2026
Brown-Forman disclosed 24 risk factors in its most recent earnings report, indicating significant challenges.
Detailed stock analysis and price target predictions suggest potential volatility and uncertainty in Brown-Forman's performance.
Mixed analyst opinions and stock forecasts could lead to fluctuating investor sentiment around Brown-Forman.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 18, 2026
Brown-Forman reported solid fiscal fourth-quarter results with net sales of US$912 million and full-year sales of US$3.93 billion, indicating robust financial health.
Multiple bullish theses on Brown-Forman Corporation (BF-B) have been highlighted by analysts, suggesting positive sentiment and potential upside.
The company's diversification in premium spirits positions it well, though there is a noted risk if demand slows more broadly.
Management reiterated fiscal 2026 guidance, providing clarity and confidence in their outlook despite expected low-single-digit declines in organic net sales and operating income.
Brown-Forman's exposure to the tequila market offers growth opportunities, though prolonged pressure in this segment could pose risks.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
BF- BF-B Brown-Forman Corporation | $12.4B | 15.7x | +0.6% | 18.2% | Hold | — |
DEO DEO Diageo plc | $44.7B | 17.1x | +2.7% | 14.7% | Hold | +38.6% |
BUD BUD Anheuser-Busch InBev SA/NV | $138.9B | 18.4x | +2.7% | 10.5% | Buy | +10.2% |
STZ STZ Constellation Brands, Inc. | $24.5B | 12.0x | +3.9% | 11.8% | Buy | +26.2% |
BEA BEAM Beam Therapeutics Inc. | $3.5B | — | +17.1% | -49.2% | Buy | +40.6% |
MGP MGPI MGP Ingredients, Inc. | $351M | 10.3x | 0.0% | -46.0% | Buy | +76.4% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
BF-B returns 6.7% total yield, led by a 3.43% dividend, raised 41 consecutive years. Buybacks add another 3.2%.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.46 | — | 3.3% | 6.9% |
| 2025 | $0.91 | +3.6% | 0.0% | 2.5% |
| 2024 | $0.88 | +5.5% | 1.8% | 3.5% |
| 2023 | $0.83 | +8.2% | 0.0% | 1.2% |
| 2022 | $0.77 | -55.4% | 0.0% | 2.6% |
Common questions answered from live analyst data and company financials.
Brown-Forman Corporation (BF-B) is rated Hold by Wall Street analysts as of 2026. Of 36 analysts covering the stock, 6 rate it Buy or Strong Buy, 23 rate it Hold, and 7 rate it Sell or Strong Sell. The bear case scenario is $20 and the bull case is $41.
BF-B trades at 15.7x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals fair versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for BF-B in 2026 are: (1) Earnings report risks — Brown-Forman disclosed 24 risk factors in its most recent earnings report, indicating significant challenges. (2) Investment analysis uncertainty — Detailed stock analysis and price target predictions suggest potential volatility and uncertainty in Brown-Forman's performance. (3) Market sentiment risk — Mixed analyst opinions and stock forecasts could lead to fluctuating investor sentiment around Brown-Forman. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates BF-B will report consensus revenue of $4.0B (+0.6% year-over-year) and EPS of $1.69 (+8.6% year-over-year) for the upcoming fiscal year. The following year, analysts project $4.0B in revenue.
A confirmed upcoming earnings date for BF-B is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.
Brown-Forman Corporation (BF-B) generated $893M in free cash flow over the trailing twelve months — a free cash flow margin of 22.7%. BF-B returns capital to shareholders through dividends (3.4% yield) and share repurchases ($400M TTM).